TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published2
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025". Published status: complete. Published value: Value not published. 2 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
24.6Bids / Report
17.4% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 391 active published awards; 367 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published29 Jul 2025, 15:34 BST
Last source update29 Jul 2025, 15:34 BST
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-04e273
What is being bought
NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025<br/>CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 <br/>CM/PHR/24/5680/02 - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026
What changed
From the official release history
  1. tender value changed
    29 Jul 2025, 15:34 BST
  2. Status changed to complete
    29 Jul 2025, 15:34 BST
  3. Official notice release published
    29 Jul 2025, 15:34 BST
  4. Submission deadline changed to published date
    29 Jul 2025, 15:34 BST
  5. Buyer information updated
    29 Jul 2025, 15:34 BST
  6. Published value updated to £4,108,145,000
    17 Feb 2025, 09:56 GMT
  7. Status changed to active
    17 Feb 2025, 09:56 GMT
  8. Official notice release published
    17 Feb 2025, 09:56 GMT
  9. Submission deadline changed to 7 Apr 2025, 13:00 BST
    17 Feb 2025, 09:56 GMT
  10. Buyer information updated
    17 Feb 2025, 09:56 GMT
Lots and requirements (2)
Published by the contracting authority
  • Lot 1 · #1
    Lot 1 - CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East
    cancelled
    Published valueNot published
    Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    Lot 2 - CM/PHR/24/5680/02 - Eculizumab and Ravulizumab for London & SOFE
    cancelled
    Published valueNot published
    Eculizumab and Ravulizumab for London & SOFE. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    29 Jul 2025, 15:34 BST
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Award active
    Not published · Not published
  13. Award active
    Not published · Not published
  14. Award active
    Not published · Not published
  15. Award active
    Not published · Not published
  16. Award active
    Not published · Not published
  17. Award active
    Not published · Not published
  18. Award active
    Not published · Not published
  19. Award active
    Not published · Not published
  20. Award active
    Not published · Not published
  21. Award active
    Not published · Not published
  22. Award active
    Not published · Not published
  23. Award active
    Not published · Not published
  24. Award active
    Not published · Not published
  25. Award active
    Not published · Not published
  26. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  27. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  28. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  29. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  30. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  31. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  32. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  33. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  34. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  35. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  36. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  37. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  38. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  39. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  40. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  41. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  42. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  43. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  44. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  45. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  46. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  47. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  48. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
  49. Contract active
    Signed 1 Jul 2025, 00:00 BST · £1
Commercial outcome and competition
Awards
Biogen
Not published · Not published · active
GlaxoSmithKline UK Limited
Not published · Not published · active
Samsung Bioepis UK Ltd
Not published · Not published · active
Pfizer Ltd
Not published · Not published · active
Janssen-Cilag Ltd
Not published · Not published · active
Celltrion Healthcare United Kingdom Limited
Not published · Not published · active
Abbvie Ltd
Not published · Not published · active
Takeda UK Ltd
Not published · Not published · active
Organon Pharmaceuticals UK Ltd
Not published · Not published · active
Alexion Pharmaceuticals
Not published · Not published · active
Orifarm UK
Not published · Not published · active
Amgen Ltd
Not published · Not published · active
CuraTeQ Biologics s.r.o.
Not published · Not published · active
Dr.Reddy's Laboratories (UK) Limited
Not published · Not published · active
Amgen Ltd
Not published · Not published · active
Samsung Bioepis UK Ltd
Not published · Not published · active
Alexion Pharmaceuticals
Not published · Not published · active
Sobi (Swedish Orphan Biovitrum Ltd)
Not published · Not published · active
Zentiva Pharma UK Ltd
Not published · Not published · active
Fresenius Kabi Limited
Not published · Not published · active
Sandoz Ltd
Not published · Not published · active
Thornton and Ross Ltd
Not published · Not published · active
Roche Products Ltd
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
Contracts
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Contract
£1 · signed 1 Jul 2025, 00:00 BST · active
Bid statistics
bids: 23
bids: 23
bids: 23
bids: 23
bids: 23
bids: 23
bids: 23
bids: 23
bids: 23
bids: 23
bids: 23
bids: 23
bids: 23
bids: 23
bids: 23
bids: 23
bids: 23
bids: 23
bids: 23
bids: 23
bids: 3
bids: 3
bids: 23
bids: 3
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 23
electronicBids: 3
electronicBids: 3
electronicBids: 3
electronicBids: 23
smeBids: 6
smeBids: 6
Buyer and organisations in this procedure

NHS England

Contracting authority GB-FTS-130973
View buyer profile

  • NHS England
    buyer
    centralPurchasingBody

    Wellington House, 133-135 Waterloo Rd, London, UKJ1, SE1 8UG
    lynne.tierney@nhs.net

  • Abbvie Ltd
    supplier

    AbbVie House Vanwall Business Park Vanwall Road Maidenhead Berkshire SL6 4UB, Maidenhead, UK

  • Accord-UK Ltd
    supplier

    Whiddon Valley Barnstaple North Devon EX32 8NS, Barnstable, UK

  • Alexion Pharmaceuticals
    supplier

    6th Floor, 2 Pancras Square, London, N1C 4AG, London, UK

  • Amgen Ltd
    supplier

    216 Cambridge Science Park, Milton Road, Cambridge, CB4 0WA, Cambridge, UK

  • Biogen
    supplier

    Building 5 Foundation Park, Roxborough Way, Maidenhead, Berkshire, England, SL6 3UD, Maidenhead, UK

  • Celltrion Healthcare United Kingdom Limited
    supplier

    The Charter Building, Charter Place, Uxbridge, UB8 1JG, Uxbridge, UK

  • CuraTeQ Biologics s.r.o.
    supplier

    Trtinova 260/1, Prague, 19600, Czech Republic, Prague, UK

  • Dr.Reddy's Laboratories (UK) Limited
    supplier

    410 Cambridge Science Park, Milton Road, Cambridge, CB4 0PE, Cambridge, UK

  • Fresenius Kabi Limited
    supplier

    Cestrian Court, Eastgate Way, Manor Park, Runcorn, Cheshire, WA7 1NT, Runcorn, UK

  • GlaxoSmithKline UK Limited
    supplier

    79 New Oxford Street, London WC1A 1DG, London, UK

  • Janssen-Cilag Ltd
    supplier

    50-100 Holmers Farm Way, High Wycombe, HP12 4EG, High Wycombe, UK

  • Organon Pharmaceuticals UK Ltd
    supplier

    145 City Road, London, EC1V 1AZ, London, UK

  • Orifarm UK
    supplier

    Breakspear Park Hemel Hempstead HP2 4TZ, Hemel Hempstead, UK

  • Pfizer Ltd
    supplier

    Walton Oaks, Dorking Road, Walton-on-the-Hill, Tadworth, Surrey KT20 7NS, Tadworth, UK

  • Roche Products Ltd
    supplier

    6 Falcon Way, Shire Park Welwyn Garden City AL7 1TW, Welwyn Garden City, UK

  • Samsung Bioepis UK Ltd
    supplier

    5th Floor, Profile West, 950 Great West Road, Brentford, Middlesex TW8 9ES, Brentford, UK

  • Sandoz Ltd
    supplier

    Maxis 1 Western Road Bracknell RG12 1RF, Bracknell, UK

  • Sobi (Swedish Orphan Biovitrum Ltd)
    supplier

    Suite 2, Riverside 3, Granta Park, Great Abington, Cambridgeshire, CB21 6AD, Abington, UK

  • Takeda UK Ltd
    supplier

    1 Kingdom Street London W2 6BD, London, UK

  • The High Court
    reviewBody

    The Strand, London, WC2A 2LL

  • Thornton and Ross Ltd
    supplier

    The Globe (3rd Floor), Bridge Street, Slaithwaite, Huddersfield, HD7 5JN, Slaithwaite, UK

  • Zentiva Pharma UK Ltd
    supplier

    Andrews House, College Road, Guildford, GU1 4QB, Guildford, UK
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published